Clinical Trials Directory

Trials / Completed

CompletedNCT00438399

Subject Preference for Scalp Psoriasis Treatment

Subject Preference Comparison Between Clobetasol Propionate Shampoo, 0.05% and Three Other Topical Corticosteroids in the Treatment of Moderate to Severe Scalp Psoriasis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
219 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The scalp is one of the most common affected sites in psoriatic patients as 79% of them have scalp involvement.It has also a psychological aspect with 31% of patients with scalp psoriasis indicating distress. Topical agents remain the mainstay of treatment for scalp psoriasis. However, they are not always ideal because they might be inconvenient and messy to use, stain or damage hair. The test shampoo, Clobetasol propionate Shampoo 0.05% (marketed in the USA under the tradename of Clobex®) was developed to provide the strongest available corticosteroid as a short-contact therapy in order to improve the chances of it being effective and reduce the potential for traditional side-effects. The objective of this study is to compare subject's overall preference between Clobetasol propionate shampoo 0.05% and three other topical corticosteroids in the treatment of moderate to severe scalp psoriasis.

Detailed description

This study will be a multi-centre, investigator blinded, randomized, cross-over, intra-individual comparison in three parallel groups. In each parallel group, Clobetasol propionate shampoo, 0.05% will be compared to one of the three chosen competitors, following a cross-over design.

Conditions

Interventions

TypeNameDescription
DRUGC. propionate - Corticosteroid 1Twice daily application
DRUGC. propionate- Corticosteroid 2Twice daily application
DRUGC. propionate -Corticosteroid 3Twice daily application
DRUGCorticosteroid 1- C. propionateTwice daily application
DRUGCorticosteroid 2 - C. propionateTwice daily application
DRUGCorticosteroid 3 - C. propionateTwice daily application

Timeline

Start date
2007-02-01
Primary completion
2008-01-01
Completion
2008-02-01
First posted
2007-02-22
Last updated
2021-02-18
Results posted
2011-12-23

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00438399. Inclusion in this directory is not an endorsement.